ÂÜÀòÂÒÂ×

Mike Abrams has a diverse work experience in the pharmaceutical and biotechnology industry. Mike is currently the Chief Scientific Officer at Abdera Therapeutics since September 2020. Prior to this role, they worked as a Consultant and Director in a self-employed capacity since October 2016. From January 2014 to September 2016, they served as the Executive Vice President and Chief Discovery Officer at Tekmira Pharmaceutical Corporation. Before that, they held the position of Director at Tekmira Pharmaceutical Corporation from 2008 to 2014. Mike also served as the VP of R&D and Chief Innovation Officer at CDRD Ventures from September 2012 to December 2013. Mike held the position of Executive Chairman at Indel Therapeutics Inc. from September 2009 to December 2013. From 2009 to 2012, Mike served as the President & CEO of Inimex Pharmaceuticals. Mike also held the position of Executive Chairman at Indel Therapeutics from 2008 to 2009. Mike's career started at AnorMED Inc., where they served as the President & CEO from 1996 to 2006.

Mike Abrams completed their Ph.D. in Chemistry from the Massachusetts Institute of Technology between 1979 and 1983.